Papers by Eric M Reiman · AgingResearch.News

Acta NeuropathologicaYesterday
Global and regional amyloid-β in explaining APOE-ε4 and sex associations with medial temporal tau: a neuropathology study
Study in peopleMechanisms
Paper
Translational Psychiatry16 Sep
Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer's disease
Study in peopleMechanisms
Paper
medRxiv1 Sep
Returning APOE and pTau-217 Results: the eSMARTER Randomized Noninferiority Clinical Trial
Preprint: trial in peopleInterventions
Paper
Alzheimer's & Dementia1 Sep
Brain-derived plasma p-tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change
Study in peopleBiomarkers
Paper

AAIC 2025 Abstract9 Jan
Blood‐based biomarker for identifying post‐mortem confirmed Cerebral Amyloid Angiopathy
Study in peopleBiomarkers
Paper
AAIC 2025 Abstract26 Dec
Characterizing Tau Accumulation and Amyloid‐Tau Interactions in the Alzheimer’s Prevention Initiative Autosomal Dominant Alzheimer’s Disease Colombia Trial and Their Implications for Advancing Drug Development
Trial in peopleMechanisms
Paper
AAIC 2025 Abstract26 Dec
Harmonizing florbetapir and PiB PET measurements of cortical A plaque burden using unpaired regions‐of‐interest features
Computational studyBiomarkers
Paper
AAIC 2025 Abstract25 Dec
Evaluation of Self‐Mediated Alternatives for Risk Testing Education and Return of Results ‐ eSMARTER: A randomized trial from the Alzheimer’s Prevention Initiative program
Trial in peopleInterventions
Paper
AAIC 2025 Abstract25 Dec
CONNECT 4 APOE : A randomized study of phone versus videoconference delivery of APOE genotype disclosure in the Generation Study
Trial in peopleInterventions
Paper
AAIC 2025 Abstract25 Dec
Study Design of Draw‐10: a weekly blood draw study to understand the biological fluctuations of plasma pTau‐217
Study in peopleBiomarkers
Paper
AAIC 2025 Abstract25 Dec
Using NULISAseq to identify biomarkers linked to postmortem Alzheimer's disease and other neurodegenerative pathologies
Study in peopleBiomarkers
Paper
AAIC 2025 Abstract25 Dec
A resource of data and samples in cognitively unimpaired 60–75‐year‐olds at increased risk of Alzheimer's disease based on their APOE4 status as heterozygotes or homozygotes
Trial in peopleAI & data
Paper
AAIC 2025 Abstract24 Dec
Plasma biomarkers of neuroinflammation and neurodegeneration in relation to cerebral glucose hypometabolism in autosomal‐dominant Alzheimer's disease
Study in peopleMechanisms
Paper
AAIC 2025 Abstract24 Dec
A resource of data and samples in cognitively unimpaired persons at six levels of Alzheimer's disease risk based on their APOE genotype
Study in peopleAI & data
Paper
AAIC 2025 Abstract23 Dec
CONNECT 4 APOE : A randomized study of phone versus videoconference delivery of APOE genotype disclosure in the Generation Study
Trial in peopleInterventions
Paper
AAIC 2025 Abstract23 Dec
Plasma biomarkers of neuroinflammation and neurodegeneration in relation to cerebral glucose hypometabolism in autosomal‐dominant Alzheimer’s disease
Study in peopleMechanisms
Paper
AAIC 2025 Abstract23 Dec
Association of Neighborhood‐Level Disadvantage with Antemortem MRI Brain Volumes in a Multi‐site Brain Bank Donor Cohort
Study in peoplePopulations
Paper
AAIC 2025 Abstract23 Dec
A comparison of four fully automated platforms for the measurement of plasma p ‐tau217 in the Alzheimer’s disease continuum
Study in peopleBiomarkers
Paper
AAIC 2025 Abstract23 Dec
Estimated age of amyloid plaque onset and impact of APOE4 in longitudinally assessed presenilin 1 E280A autosomal dominant Alzheimer’s disease mutation carriers
Trial in peoplePopulations
Paper
AAIC 2025 Abstract23 Dec
Can primary prevention of Alzheimer's disease be cost‐effective?
Computational studyInterventions
Paper